Trek Financial LLC Buys 16,098 Shares of Oracle Corporation $ORCL

Trek Financial LLC increased its stake in Oracle Corporation (NYSE:ORCL) by 146.7% during the second quarter, Holdings Channel reports. The firm owned 27,073 shares of the enterprise software provider’s stock after acquiring an additional 16,098 shares during the period. Trek Financial LLC’s holdings in Oracle were worth $5,919,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Vanguard Group Inc. raised its holdings in shares of Oracle by 2.1% during the 2nd quarter. Vanguard Group Inc. now owns 164,278,874 shares of the enterprise software provider’s stock worth $35,916,290,000 after buying an additional 3,353,461 shares in the last quarter. Northern Trust Corp grew its position in Oracle by 0.6% in the first quarter. Northern Trust Corp now owns 19,741,423 shares of the enterprise software provider’s stock valued at $2,760,048,000 after acquiring an additional 120,889 shares during the last quarter. Norges Bank acquired a new position in Oracle during the second quarter worth about $4,275,378,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Oracle by 0.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 13,884,524 shares of the enterprise software provider’s stock worth $1,941,195,000 after acquiring an additional 59,164 shares during the last quarter. Finally, Amundi lifted its holdings in shares of Oracle by 3.3% in the first quarter. Amundi now owns 12,736,855 shares of the enterprise software provider’s stock worth $1,749,280,000 after acquiring an additional 409,691 shares during the last quarter. Institutional investors and hedge funds own 42.44% of the company’s stock.

Insider Activity

In other Oracle news, Director Jeffrey Berg sold 49,365 shares of the firm’s stock in a transaction on Tuesday, October 28th. The shares were sold at an average price of $283.02, for a total value of $13,971,282.30. Following the completion of the sale, the director directly owned 151,999 shares in the company, valued at approximately $43,018,756.98. This trade represents a 24.52% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director William G. Parrett sold 11,500 shares of the company’s stock in a transaction dated Friday, September 12th. The shares were sold at an average price of $306.00, for a total transaction of $3,519,000.00. Following the transaction, the director owned 17,764 shares in the company, valued at $5,435,784. This represents a 39.30% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 204,254 shares of company stock worth $60,227,807. Company insiders own 40.90% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on ORCL. JMP Securities reaffirmed a “market outperform” rating and set a $342.00 price target on shares of Oracle in a report on Friday, October 17th. Evercore ISI boosted their target price on shares of Oracle from $350.00 to $385.00 and gave the stock an “outperform” rating in a research note on Friday, October 17th. Royal Bank Of Canada reiterated a “sector perform” rating and set a $310.00 price target on shares of Oracle in a report on Friday, October 17th. Robert W. Baird cut their price objective on Oracle from $365.00 to $315.00 and set an “outperform” rating on the stock in a report on Tuesday, November 18th. Finally, BNP Paribas set a $377.00 price objective on Oracle in a research report on Wednesday, September 10th. Three equities research analysts have rated the stock with a Strong Buy rating, twenty-eight have given a Buy rating, eleven have issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $323.68.

Oracle Trading Up 0.1%

ORCL opened at $201.22 on Wednesday. Oracle Corporation has a twelve month low of $118.86 and a twelve month high of $345.72. The company has a fifty day moving average of $257.95 and a 200-day moving average of $238.96. The stock has a market cap of $573.63 billion, a PE ratio of 46.58, a price-to-earnings-growth ratio of 2.96 and a beta of 1.51. The company has a quick ratio of 0.62, a current ratio of 0.62 and a debt-to-equity ratio of 3.33.

Oracle (NYSE:ORCL) last issued its quarterly earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 EPS for the quarter, missing analysts’ consensus estimates of $1.48 by ($0.01). Oracle had a net margin of 21.08% and a return on equity of 72.93%. The firm had revenue of $14.93 billion for the quarter, compared to the consensus estimate of $15.04 billion. During the same period last year, the company posted $1.39 EPS. The business’s revenue was up 12.2% compared to the same quarter last year. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. On average, sell-side analysts predict that Oracle Corporation will post 5 EPS for the current year.

Oracle Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, October 23rd. Shareholders of record on Thursday, October 9th were paid a $0.50 dividend. The ex-dividend date of this dividend was Thursday, October 9th. This represents a $2.00 annualized dividend and a yield of 1.0%. Oracle’s payout ratio is 46.30%.

Oracle Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.